SCYNEXIS Statistics
Total Valuation
SCYNEXIS has a market cap or net worth of $32.98 million. The enterprise value is -$9.42 million.
Important Dates
The last earnings date was Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SCYNEXIS has 39.02 million shares outstanding. The number of shares has increased by 2.03% in one year.
| Current Share Class | 39.02M |
| Shares Outstanding | 39.02M |
| Shares Change (YoY) | +2.03% |
| Shares Change (QoQ) | +0.63% |
| Owned by Insiders (%) | 2.24% |
| Owned by Institutions (%) | 23.36% |
| Float | 34.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.75 |
| Forward PS | 1.54 |
| PB Ratio | 0.74 |
| P/TBV Ratio | 0.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.20, with a Debt / Equity ratio of 0.05.
| Current Ratio | 5.20 |
| Quick Ratio | 5.04 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -20.16 |
Financial Efficiency
Return on equity (ROE) is -37.22% and return on invested capital (ROIC) is -37.22%.
| Return on Equity (ROE) | -37.22% |
| Return on Assets (ROA) | -27.12% |
| Return on Invested Capital (ROIC) | -37.22% |
| Return on Capital Employed (ROCE) | -73.37% |
| Revenue Per Employee | $116,321 |
| Profits Per Employee | -$697,036 |
| Employee Count | 28 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -372,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.98% in the last 52 weeks. The beta is 1.64, so SCYNEXIS's price volatility has been higher than the market average.
| Beta (5Y) | 1.64 |
| 52-Week Price Change | -51.98% |
| 50-Day Moving Average | 0.77 |
| 200-Day Moving Average | 1.00 |
| Relative Strength Index (RSI) | 61.97 |
| Average Volume (20 Days) | 204,563 |
Short Selling Information
The latest short interest is 519,388, so 1.33% of the outstanding shares have been sold short.
| Short Interest | 519,388 |
| Short Previous Month | 595,132 |
| Short % of Shares Out | 1.33% |
| Short % of Float | 1.50% |
| Short Ratio (days to cover) | 2.71 |
Income Statement
In the last 12 months, SCYNEXIS had revenue of $3.26 million and -$19.52 million in losses. Loss per share was -$0.40.
| Revenue | 3.26M |
| Gross Profit | 3.26M |
| Operating Income | -36.56M |
| Pretax Income | -34.72M |
| Net Income | -19.52M |
| EBITDA | n/a |
| EBIT | -36.56M |
| Loss Per Share | -$0.40 |
Full Income StatementBalance Sheet
The company has $44.79 million in cash and $2.39 million in debt, giving a net cash position of $42.40 million or $1.09 per share.
| Cash & Cash Equivalents | 44.79M |
| Total Debt | 2.39M |
| Net Cash | 42.40M |
| Net Cash Per Share | $1.09 |
| Equity (Book Value) | 44.47M |
| Book Value Per Share | 1.14 |
| Working Capital | 45.64M |
Full Balance SheetCash Flow
| Operating Cash Flow | -24.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | -24.10M |
| FCF Per Share | -$0.62 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,122.57% |
| Pretax Margin | -610.65% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |